High dose and hepatobiliary dysfunction are associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin: a retrospective study
Abstract Purpose In clinical practice, the risk factors for pegylated liposomal doxorubicin-related hand-foot syndrome remain unclear. The purpose of this study was to determine the risk factors associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin. Metho...
Saved in:
Main Authors: | Yanfang Zhao (Author), Wenjia Su (Author), Guohua Liang (Author), Xiaoyu Shan (Author), Weiwei Ma (Author), Dabei Tang (Author), Liru Li (Author), Xingjian Niu (Author), Shu Zhao (Author), Qingyuan Zhang (Author), Wenhui Zhao (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pegylated liposomal doxorubicin in ovarian cancer
by: Robert Strother, et al.
Published: (2009) -
Pegylated liposomal doxorubicin in the management of ovarian cancer
by: Gabriella Ferrandina, et al.
Published: (2010) -
Pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia
by: Joana Moreira-Barros, et al.
Published: (2018) -
Prolonged use of pegylated liposomal doxorubicin in gynecologic malignancies
by: S. Yost, et al.
Published: (2019) -
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
by: Zhen Yuan, et al.
Published: (2021)